These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Consensus development summaries. The management of clinically localized prostate cancer. National Institutes of Health. Conn Med; 1987 Sep; 51(9):607-10. PubMed ID: 3311616 [No Abstract] [Full Text] [Related]
3. Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer. Hennenfent BR Br J Urol; 1998 Jul; 82(1):166. PubMed ID: 9698691 [No Abstract] [Full Text] [Related]
4. Editorial: Improving outcomes for primary and salvage therapy of localized prostate cancer. Schellhammer PF J Urol; 2003 Nov; 170(5):1841-2. PubMed ID: 14532788 [No Abstract] [Full Text] [Related]
5. Consensus statement: the Management of Clinically Localized Prostate Cancer. National Institutes of Health Consensus Development Panel. NCI Monogr; 1988; (7):3-6. PubMed ID: 3050539 [No Abstract] [Full Text] [Related]
10. [Cancer of the prostate: what treatment for what stage?]. Vanden Bossche M Rev Med Brux; 1999 Sep; 20(4):A206-11. PubMed ID: 10523894 [TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of prostate cancer]. Auvert J Ann Urol (Paris); 1999; 33(4):259-62. PubMed ID: 10510707 [No Abstract] [Full Text] [Related]
12. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer. Dahm P; Yeung LL; Chang SS; Cookson MS J Urol; 2008 Aug; 180(2):451-9; discussion 460. PubMed ID: 18550100 [TBL] [Abstract][Full Text] [Related]
13. The management of clinically localized prostate cancer. A summary of the Consensus Statement of the National Institutes of Health. Halperin EC; Fraser RW; Hughes J N C Med J; 1988 Feb; 49(2):75-9. PubMed ID: 3278241 [No Abstract] [Full Text] [Related]
14. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy. D'Amico A BJU Int; 2007 Jan; 99 Suppl 1():13-6; discussion 17-8. PubMed ID: 17229162 [TBL] [Abstract][Full Text] [Related]